TNFRSF10B and cancer: In the second phase of clinical trials, a humanized variant of the stimulating mouse monoclonal antibody TRa-8 targets DR5, initiating apoptosis across human cancer cell lines via a caspase cascade (Forero‐Torres et al., 2013; Rajeshkumar et al., 2010)